Wouter Roorda, Ph.D.
Vice President of Chemistry and Intellectual Property
Dr. Roorda leads the analytical chemistry activities at Nano Precision Medical and heads up the development of the Intellectual Property portfolio of the company.
Dr. Roorda has more than 35 years of academic and industry experience with controlled drug delivery, medical devices, drug-device combinations, and drug- and protein-formulation. In his Ph.D. studies, he developed and characterized a hydrogel-based drug delivery technology from polymer synthesis to testing in human volunteers. At Alza Corporation, he developed a number of formulations for implantable drug delivery systems intended for low molecular weight drugs as well as macromolecules.
As a research scientist at Guidant Corporation, Dr. Roorda pioneered some of the earliest studies on the Xience V drug eluting stent program, and after the acquisition by Abbott Labs, he assumed responsibility for new product concept generation and additional IP portfolio development as a director of R&D for the endovascular division. For his work on the Xience V stent, he was awarded the Volwiler Outstanding Research Team award, the highest scientific team award at Abbott Laboratories.
Dr. Roorda has a Ph.D. from the University of Leiden, The Netherlands, and he is a registered Patent Agent. He is an inventor on 84 US patents.